Malta - angličtina - Medicines Authority

aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - glimepiride - tablet - glimepiride - drugs used in diabetes

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - glimepiride, quantity: 4 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate; povidone; indigo carmine aluminium lake; magnesium stearate - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with noninsulin dependant diabetes mellitus (type 2 diabetes).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - glimepiride, quantity: 3 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate; povidone; iron oxide yellow; magnesium stearate - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with noninsulin dependant diabetes mellitus (type 2 diabetes).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - glimepiride, quantity: 2 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate; povidone; iron oxide yellow; magnesium stearate; indigo carmine aluminium lake - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with noninsulin dependant diabetes mellitus (type 2 diabetes).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - glimepiride, quantity: 1 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate; povidone; iron oxide red; magnesium stearate - as an adjunct to diet, exercise and weight loss, to lower the blood glucose in patients with noninsulin dependant diabetes mellitus (type 2 diabetes).

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - glimepiride - oral tablet - 1mg

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - clove bud oil, quantity: 20 mg; artemisia absinthium, quantity: 500 microlitre (equivalent: artemisia absinthium, qty 100 mg; equivalent: thujone, qty 20 microlitre); stemona sessilifolia, quantity: 200 mg (equivalent: stemona sessilifolia, qty 1 g); juglans nigra, quantity: 1 ml (equivalent: juglans nigra, qty 100 mg) - tablet, film coated - excipient ingredients: magnesium stearate; calcium hydrogen phosphate dihydrate; sodium starch glycollate; microcrystalline cellulose; maltodextrin; hypromellose; colloidal anhydrous silica - traditionally used in western herbal medicine to decrease/reduce/relieve flatulence/carminative ; traditionally used in chinese medicine to vermifuge/helps remove intestinal threadworms/pinworms ; traditionally used in western herbal medicine to vermifuge/helps remove intestinal threadworms/pinworms ; traditionally used in western herbal medicine to enhance/promote healthy digestion ; traditionally used in western herbal medicine to bitter tonic/stimulate gastric secretions ; traditionally used in western herbal medicine to antispasmodic/spasmolytic

Spojené státy - angličtina - NLM (National Library of Medicine)

roerig - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 25 mg - zoloft is indicated for the treatment of the following [see clinical studies (14)] : zoloft is contraindicated in patients: in addition to the contraindications for all zoloft formulations listed above, zoloft oral solution is contraindicated in patients: overall, available published epidemiologic studies of pregnant women exposed to sertraline in the first trimester suggest no difference in major birth defect risk compared to the background rate for major birth defects in comparator populations. some studies have reported increases for specific major birth defects; however, these study results are inconclusive [see data] . there are clinical considerations regarding neonates exposed to ssris and snris, including zoloft, during the third trimester of pregnancy [see clinical considerations] . although no teratogenicity was observed in animal reproduction studies, delayed fetal ossification was observed when sertraline was administered during the period of organogenesis at doses less than the maximum recommende

Spojené státy - angličtina - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 50 mg - zoloft is indicated for the treatment of the following [see clinical studies (14)] : - major depressive disorder (mdd) - obsessive-compulsive disorder (ocd) - panic disorder (pd) - posttraumatic stress disorder (ptsd) - social anxiety disorder (sad) - premenstrual dysphoric disorder (pmdd) zoloft is contraindicated in patients: - taking, or within 14 days of stopping, maois, (including the maois linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome [see warnings and precautions (5.2), drug interactions (7.1)] . - taking pimozide [see drug interactions (7.1)] . - with known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema) [see adverse reactions (6.1, 6.2)]. in addition to the contraindications for all zoloft formulations listed above, zoloft ora

Spojené státy - angličtina - NLM (National Library of Medicine)

cardinal health - sertraline hydrochloride (unii: uti8907y6x) (sertraline - unii:quc7nx6wmb) - sertraline 50 mg - sertraline hydrochloride is indicated for the treatment of major depressive disorder in adults. the efficacy of sertraline hydrochloride in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the dsm-iii category of major depressive disorder (see clinical trials under clinical pharmacology). a major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should include at least 4 of the following 8 symptoms: change in appetite, change in sleep, psychomotor agitation or retardation, loss of interest in usual activities or decrease in sexual drive, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, and a suicide attempt or suicidal ideation. the antidepressant action of sertraline hydrochloride in hospitalized depressed patients